GL1X · GenesisL1 explorer

MolNFT v1 · #105243 · protein

Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinase state

4QYY · Mitogen-activated protein kinase 1: “Discovery of novel, dual mechanism ERK inhibitors by affinity selection screening of an inactive kinase state”. X-ray diffraction, 2 ligands (3G7, SO4), 4 pockets (best druggability 0.70). MolNFT…

PDB
4QYY
Type
protein
Length
337 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Mitogen-activated protein kinase 1
EC
2.7.11.24
UniProt
P63086
Ligands
3G7, SO4
Pockets
4 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 41% helix, 15% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AMitogen-activated protein kinase 1 (EC 2.7.11.24)protein33741% helix, 15% strandP63086

Ligands and binding sites

  • 3G7 · (3R)-1-{2-[4-(4-acetylphenyl)piperazin-1-yl]-2-oxoethyl}-N-(3-chloro-4-hydroxyphenyl)pyrrolidine-3-carboxamide · ligand · chains A
  • SO4 · Sulfate ion · ion · 3 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 2 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14710.700.80433G7
21220.520.8131empty
31370.490.7920SO4
4970.390.7614empty

Compared structures

  • 4QYY · Discovery of Novel, Dual Mechanism ERK Inhibitors by Affinity Selection Screening of an… · the same entry in another collection · chain A against A, TM-score 1.00
  • P63086 · AlphaFold monomer V2.0 prediction for mitogen-activated protein kinase 1 (P63086) · a predicted model of the same protein · chain A against A, TM-score 0.99

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.